Source: LHGDN

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0017638
Disease: Glioma
Glioma
0.600 Biomarker LHGDN The present findings of the frequent and variable p14 gene abnormalities, including rare-type ones with or without sufficient mutational effect in glioma cell lines, might be of value for better understanding of the p14 gene and its related pathways in glioma carcinogenesis. 18415661

2008

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0017638
Disease: Glioma
Glioma
0.600 GeneticVariation LHGDN Frequent homozygous deletion of p16/CDKN2A gene in malignant gliomas of Iranian patients. 19086579

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0017638
Disease: Glioma
Glioma
0.600 Biomarker LHGDN These findings support a role for p16 and p14ARF as modulators of the radio-and chemosensitivity of gliomas. 16786135

2006

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0017638
Disease: Glioma
Glioma
0.600 GeneticVariation LHGDN P53 gene mutation and expression of MDM2, P53, P16 protein and their relationship in human glioma. 16696307

2005

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0017638
Disease: Glioma
Glioma
0.600 Biomarker LHGDN Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells. 12698196

2003